Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:241 (2 February), doi:10.1136/bmj.39472.537697.DB
Rory Watson
1 Brussels
| The first 150 words of the full text of this article appear below. |
European governments are being urged to take preventive action against cervical cancer by organising nationwide vaccination programmes for young girls against the human papillomavirus (HPV).
The advice from the Stockholm based European Centre for Disease Prevention and Control (ECDPC) is contained in its latest scientific report, which was released at the European Cervical Cancer Summit in Brussels last week. However, it insists that this is no substitute for screening programmes.
Johan Giesecke, the ECDPCs chief scientist, said, "Vaccinating young adolescent girls against HPV is likely to reduce the number of women who develop cervical cancer, provided that cervical cancer screening programmes are maintained."
Several countries, notably the United Kingdom, France, Germany, Italy, and Austria, have already launched vaccination programmes to protect against genital HPV infections, which can be acquired with the onset of sexual activity and are the primary cause of cervical cancer. Other countries are considering similar action.
The
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
What can you learn from this BMJ paper? Read Leanne Tite's Paper+